Clinical Trial Update: Efficacy and Safety of Different Concentrations of Mapracorat Ointment Over 4 Weeks in Atopic Dermatitis (AD) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update assessing the efficacy and safety of different concentrations of Mapracorat ointment over 4 weeks in patients with Atopic Dermatit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Mapracorat ointment (mapracorat)

Snippet

Sponsor: Bayer | Conditions: Atopic Dermatitis, Eczema | Phase 2 | Status: COMPLETED